NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) 

3210 Merryfield Row

San Diego  California  92121  U.S.A.
Phone: 858-450-2000 Fax: n/a


SEARCH JOBS


Combining scientific innovation with global healthcare experience, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), creates innovative, high-value medicines to treat unmet medical needs for patients around the world. J&JPRD's expertise spans a variety of therapeutic areas including anti-infectives, reproductive health, central nervous system disorders and pain. It is a fully integrated pharmaceutical R&D company employing some of the world’s most advanced research and development technology and a community of experts involved in drug discovery, evaluation, and global development.

For more information about our company, visit: www.jnjpharmarnd.com


 Key Statistics


Email:
Ownership:
Web Site: Johnson & Johnson Pharmaceutical Research & Development, LLC (CA)
Employees:
Symbol: 
 



Industry
Biotechnology


Collaborations

Sunesis Pharmaceuticals, Inc.  Inflammatory and Autoimmune Diseases

Entelos, Inc. 





 Company News
FDA Approves Johnson & Johnson Pharmaceutical Research & Development, LLC (CA)'s (JOBS) INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 8/3/2009 7:45:20 AM    More...
PPD, Inc. (PPDI) Confirms Johnson & Johnson Pharmaceutical Research & Development, LLC (CA)'s (JOBS) Completion of Additional Phase III Studies Providing Expanded Safety and Efficacy Data for Priligy 6/10/2009 7:07:24 AM    More...
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Release: Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain 5/7/2009 12:10:39 PM    More...
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Announces FDA Filings for Paliperidone Palmitate and INVEGA(R) 2/6/2009 8:31:36 AM    More...
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Release: Rivaroxaban Reduces Symptomatic VTE & Death Following Knee or Hip Replacement Surgery by More Than 50% Compared to Enoxaparin in Pooled Analysis of the RECORD Clinical Trial Program 12/8/2008 10:48:12 AM    More...
FDA Approves Johnson & Johnson (JNJ)'s (JOBS) Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 11/22/2008 2:56:10 PM    More...
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Release: Rivaroxaban Phase II Dose-Ranging Study Demonstrates Encouraging Response Rates in Treatment of Acute Coronary Syndrome Patients 11/10/2008 9:24:33 AM    More...
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Release: New Data Show In Vitro Potency Of Doripenem Against Resistant Bacteria 10/27/2008 3:22:15 PM    More...
Johnson & Johnson Pharmaceutical Research & Development, LLC (CA) Submits New Drug Application to FDA for Carisbamate 10/24/2008 8:36:35 AM    More...
Tekmira Pharmaceuticals Corporation Announces Presentation of Data Using SNALP RNAi Delivery Technology 10/22/2008 8:31:08 AM    More...
12345678